The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in Macrophages
Open accessAbstract
Endoplasmic reticulum (ER) stress promotes tumor cell escape from immunosurveillance. However, the underlying mechanisms remain unknown. We hypothesized that ER stress induces hepatocellular carcinoma (HCC) cells to release exosomes, which attenuate antitumor immunity by modulating the expression of programmed death ligand 1 (PD‐L1) in macrophages. In this study, we demonstrated that expression of several ER stress markers (glucose‐regulated protein 78, activating transcription factor 6, protein kinase R–like ER kinase, and inositol‐requiring enzyme 1α) was up‐regulated in HCC tissues and negatively correlated with the overall survival and clinicopathological scores in patients with HCC. Expression of ER stress–related proteins positively correlated with CD68 + macrophage recruitment and PD‐L1 expression in HCC tissues. High‐throughput sequencing analysis identified miR‐23a‐3p as one of the most abundant microRNAs in exosomes derived from tunicamycin (TM)‐treated HCC cells (Exo‐TMs). miR‐23a‐3p levels in HCC tissues negatively correlated with overall survival. Treatment with Exo‐TMs up‐regulated the expression of PD‐L1 in macrophages in vitro and in vivo . Bioinformatics analysis suggests that miR‐23a‐3p regulates PD‐L1 expression through the phosphatase and tensin homolog (PTEN)–phosphatidylinositol 3‐kinase–protein kinase B (AKT) pathway. This notion was confirmed by in vitro transfection and coculture experiments, which revealed that miR‐23a‐3p inhibited PTEN expression and subsequently elevated phosphorylated AKT and PD‐L1 expression in macrophages. Finally, coculture of T cells with Exo‐TM–stimulated macrophages decreased CD8 + T‐cell ratio and interleukin‐2 production but increased T‐cell apoptosis in vitro . Conclusion : ER‐stressed HCC cells release exosomes to up‐regulate PD‐L1 expression in macrophages, which subsequently inhibits T‐cell function through an exosome miR‐23a–PTEN–AKT pathway. Our findings provide insight into the mechanism how tumor cells escape from antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Abundant expression of miR-23a-3p was found in the exosomes of HCC cells treated with tetracycline, resulting in inhibition of PTEN mRNA level.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The exosomes can effectively transmit the regulatory effects of miR-23 as a channel.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Subsequently, it enhances the expression of phosphorylated AKT and PD-L1 in macrophages and inhibits T cell function by functioning on the miR-23a-PTEN-AKT pathway [77].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Llovet, J. M., Burroughs, A. K., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,637
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
From endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · cited 2×
“(26,27) For example, metastatic breast cancer cell–secreted exosomes transfer miR-105 to endothelial cells and promote tumor cell metastasis by destroying tight junctions and the integrity of endothelial monolayers.(28) Furthermore, exosomes derived from HCC cells can transfer specific miRNAs to enhance recipient cell…”
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
Cited by
Sorted by citations
Items 101–200 of 451
Guo, J., Zhong, X., Tan, Q., Yang, S., Liao, J., Zhuge, J., Hong, Z., Deng, Q., & Zuo, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03991-3 · Cited by 45
Lu, Y., Zheng, J., Lin, P., Lin, Y., Zheng, Y., Mai, Z., Chen, X., Xia, T., Zhao, X., & Cui, L. (2024) · ACS Nano · doi:10.1021/acsnano.4c09190 · Cited by 50
Li, Y., You, J., Zou, Z., Sun, G., Shi, Y., Sun, Y., Xu, S., & Zhang, X. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.114222 · Cited by 48
Self-citationHe, C., Wei, H., Liu, J., Fan, L., Wang, H., & Sun, G. (2020) · Oncology Letters · doi:10.3892/ol.2020.11609 · Cited by 46
Self-citationLi, P., Luo, X., Xie, Y., Li, P., Hu, F., Chu, J., Chen, X., Song, W., Wang, A., Tian, G., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.020 · Cited by 45
Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma
Zhang, Q., Li, H., Liu, Y., Li, J., Wu, C., & Tang, H. (2022) · Current Oncology · doi:10.3390/curroncol29080427 · Cited by 46
Guo, Z., Li, G., Shen, L., Pan, J., Dou, D., Gong, Y., Shi, W., Sun, Y., Zhang, Y., Ma, K., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s478435 · Cited by 45
Self-citationExtracellular MicroRNAs as Intercellular Mediators and Noninvasive Biomarkers of Cancer
Ortíz-Quintero, B. (2020) · Cancers · doi:10.3390/cancers12113455 · Cited by 48
MicroRNA signature in liver cancer
Ghafouri‐Fard, S., Tamizkar, K. H., Hussen, B. M., & Taheri, M. N. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153369 · Cited by 45
Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link
Nie, Z., Chen, M., Wen, X., Gao, Y., Huang, D., Cao, H., Peng, Y., Guo, N., Ni, J., & Zhang, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683940 · Cited by 43
Synergism in actions of HBV with aflatoxin in cancer development
Jin, J., Kouznetsova, V. L., Kesari, S., & Tsigelny, I. F. (2023) · Toxicology · doi:10.1016/j.tox.2023.153652 · Cited by 43
The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma
Chen, Z., Jiang, L., Liang, L., Koral, K., Zhang, Q., Zhao, L., Lu, S., & Tao, J. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.014 · Cited by 43
Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers
Jia, Z., Jia, J., Yao, L., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900155 · Cited by 44
ncRNA-mediated fatty acid metabolism reprogramming in HCC
Xu, K., Xia, P., Chen, X., Ma, W., & Yuan, Y. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.02.007 · Cited by 42
Liu, C., Zhou, X., Qian, L., Zeng, H., Sun, Q., Chen, Y., Wu, D., & Liu, L. (2020) · Oncogene · doi:10.1038/s41388-020-01521-7 · Cited by 42
Zhou, B., Lu, D., Wang, A., Cui, J., Zhang, L., Li, J., Fan, L., Wei, W., Liu, J., & Sun, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.014 · Cited by 42
Self-citationMicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages
Chen, C., Liu, J., & Luo, Y. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900452 · Cited by 41
Self-citationZhang, Y., Zhang, X., Zhang, H., Song, P., Pan, W., Xu, P., Wang, G., Hu, P., Wang, Z., Huang, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.811164 · Cited by 42
Self-citationThe role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD
Cheng, Z., Yang, L., & Chu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.002 · Cited by 40
Ghafouri‐Fard, S., Niazi, V., Hussen, B. M., Omrani, M. D., Taheri, M. N., & Basiri, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653296 · Cited by 40
Tian, B., Zhou, L., Wang, J., & Yang, P. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108157 · Cited by 39
Adamczyk‐Grochala, J., Błoniarz, D., Zielińska, K., Lewińska, A., & Wnuk, M. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01779-0 · Cited by 38
Cui, J., Liu, J., Fan, L., Zhu, Y., Zhou, B., Wang, Y., Wei, H., Wei, W., & Sun, G. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100851 · Cited by 40
Self-citationMicroRNAs: As Critical Regulators of Tumor- Associated Macrophages
Chatterjee, B., Saha, P., Bose, S., Shukla, D., Chatterjee, N., Kumar, S., Tripathi, P. P., & Srivastava, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197117 · Cited by 37
Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer
Qin, L., Zhan, Z., Wei, C., Li, X., Zhang, T., & Li, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12060 · Cited by 38
Self-citationRole of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma
Chen, X., Chi, H., Zhao, X., Pan, R., Wei, Y., & Han, Y. (2022) · Journal of Oncology · doi:10.1155/2022/2521025 · Cited by 38
Hu, Z., Zhang, H., Liu, W., Yin, Y., Jiang, J., Yan, C., Wang, Y., & Li, L. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-96 · Cited by 38
Tarin, M., Oryani, M. A., Javid, H., & Karimi‐Shahri, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114519 · Cited by 38
Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
Zeng, Y., Hu, S., Luo, Y., & He, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092365 · Cited by 38
Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
Lin, W., Fang, J., Wei, S., He, G., Liu, J., Li, X., Peng, X., Dai, L., Yang, S., Li, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01236-8 · Cited by 41
Self-citationInfluencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics
Ye, Z., Li, G., & Lei, J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01340-w · Cited by 39
Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
Li, Z., Sun, G., Sun, G., Cheng, Y., Wu, L., Wang, Q., Lv, C., Zhou, Y., Xia, Y., & Tang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.771335 · Cited by 37
Self-citationDuan, Y., Zhou, M., Ye, B., Yue, K., Qiao, F., Wang, Y., Lai, Q., Wu, Y., Cao, J., Wu, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06587-9 · Cited by 35
Gramantieri, L., Giovannini, C., Piscaglia, F., & Fornari, F. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s268292 · Cited by 36
Ahmad, A. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.001 · Cited by 35
MicroRNA—A Tumor Trojan Horse for Tumor-Associated Macrophages
Syed, S. N., Frank, A.-C., Raue, R., & Brüne, B. (2019) · Cells · doi:10.3390/cells8121482 · Cited by 37
Liu, P., Wei, J., Mao, F., Xin, Z., Duan, H., Du, Y., Wang, X., Li, Z., Qian, J., & Yao, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641487 · Cited by 33
A review on the current literature regarding the value of exosome miRNAs in various diseases
Li, S., Lv, D., Yang, H. J., Lü, Y., & Jia, Y. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2232993 · Cited by 32
Otmani, K., Rouas, R., Lagneaux, L., Krayem, M., Duvillier, H., Berehab, M., & Lewalle, P. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01259-1 · Cited by 33
RetractedWang, M.-D., Xiang, H., Zhang, L., & Wang, C. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101509 · Cited by 32
Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum
Girigoswami, K., Pallavi, P., & Girigoswami, A. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2284684 · Cited by 35
Wang, B., Cheng, D., Ma, D., Chen, R., Li, D., Zhao, W., Fang, C., & Ji, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01473-5 · Cited by 36
Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis
Ma, Z., Sun, Y. L., Yu, Y., Xiao, W., Xiao, Z., Zhong, T., Xiang, X., & Li, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01669-9 · Cited by 33
Li, W., Wang, X., Li, C., Chen, T., & Yang, Q. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.12.002 · Cited by 33
Xie, Q., Zhang, P., Wang, Y., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958720 · Cited by 35
Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
Wu, Y., Fu, H., Hao, J., Yang, Z., Qiao, X., Li, Y., Zhao, R., Lin, T., Wang, Y., & Wang, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342728 · Cited by 33
Self-citationLi, X., Yu, X., Zhou, D., Chen, B., Li, W., Zheng, X., Zeng, H., Long, L., & Zhou, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00737 · Cited by 32
Self-citationNoncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
Zhou, Z., Wang, Z., Gao, J., Lin, Z., Wang, Y., Shan, P., Li, M., Zhou, T., & Li, P. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.03.002 · Cited by 33
Noncoding RNAs as sensors of tumor microenvironmental stress
Lv, Y., Lv, Y., Wang, Z., Yuan, K., & Zeng, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02433-y · Cited by 31
Li, Z., Duan, D., Li, L., Peng, D., Ming, Y., Ni, R., & Liu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1382256 · Cited by 35
Endoplasmic Reticulum Stress in Cancer
Zhou, R., Wang, W., Li, B., Zhu, L., Huang, J., & Li, X. (2025) · MedComm · doi:10.1002/mco2.70263 · Cited by 39
Self-citationLiang, B., Hu, X., Ding, Y., & Liu, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30197 · Cited by 30
Xia, T., Tian, H., Zhang, K., Zhang, S., Chen, W., Shi, S., & You, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08712-9 · Cited by 30
Hou, H., Wang, Y., Yang, L., & Wang, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14113 · Cited by 31
Qiu, Y., Lu, G., Li, N., Hu, Y., Tan, H., & Jiang, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1327281 · Cited by 33
Shi, S., Zhang, H.-P., Yang, C., Li, L., Shen, Y., & Zhang, Y. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152986 · Cited by 29
Reed, T., Schorey, J. S., & D’Souza‐Schorey, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.746432 · Cited by 31
Li, X., Zhou, D., Cai, Y., Yu, X., Zheng, X., Chen, B., Li, W., Zeng, H., Hassan, M., Zhao, Y. H., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-021-00370-1 · Cited by 30
Self-citationInteractions between endoplasmic reticulum stress and extracellular vesicles in multiple diseases
Ye, J., & Liu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955419 · Cited by 29
Zhou, Z., Hu, Y., Wu, Y., Qi, Q., Wang, J., Chen, L., & Wang, F. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.09.010 · Cited by 31
Self-citationAfra, F., Mahboobipour, A. A., Farid, A. S., & Ala, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115104 · Cited by 30
Zhang, Y. L., Li, X., Chen, H., Li, J., Guo, X., Fang, Y., Chen, L., Li, K., Zhang, Y., Kong, F., et al. (2024) · Advanced Science · doi:10.1002/advs.202404089 · Cited by 28
Self-citationResearch Progress in the Application of Exosomes in Immunotherapy
Zhang, X., Xu, D., Song, Y., Rong, H., & Wang, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.731516 · Cited by 29
MicroRNAs: Small molecules with big impacts in liver injury
Halim, A. S. A., Rudayni, H. A., Chaudhary, A. A., & Ali, M. A. M. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30908 · Cited by 27
Li, Y., Zhao, W., Fu, R., Ma, Z., Hu, Y., Liu, Y., & Ding, Z. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01031-z · Cited by 28
Self-citationExosomal circRNAs: Novel biomarkers and therapeutic targets for gastrointestinal tumors
Wang, D., Li, R., Jiang, J., Qian, H., & Xu, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114053 · Cited by 29
Ji, W., Bai, J., & Ke, Y. (2023) · Environmental Toxicology · doi:10.1002/tox.23767 · Cited by 28
Aseervatham, J. (2023) · Biology · doi:10.3390/biology12050710 · Cited by 29
Anticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats
Song, J., Ding, W., Liu, B., Liu, D., Xia, Z., Zhang, L., Cui, L., Luo, Y., Jia, X., & Feng, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11135 · Cited by 27
Thomas, L., Florio, T., & Perez-Castro, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.590034 · Cited by 28
The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma
Wang, W., Hao, L., Song, H., Chu, X., & Wang, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.790916 · Cited by 27
Extracellular vesicles participate in macrophage-involved immune responses under liver diseases
Shao, J., Li, S., Liu, Y., & Zheng, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117094 · Cited by 25
Papadakos, S. P., Machairas, N., Stergiou, I. Ε., Arvanitakis, K., Germanidis, G. S., Frampton, A. E., & Theocharis, S. E. (2023) · Cells · doi:10.3390/cells12162036 · Cited by 30
Luo, H., Hu, B., Gu, X.-R., Chen, J., Fan, X., Zhang, W., Wang, R., He, X.-D., Guo, W., Dai, N., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02201-w · Cited by 25
Hsa-miRNA-23a-3p promotes atherogenesis in a novel mouse model of atherosclerosis
Guo, J., Mei, H., Sheng, Z., Meng, Q., Véniant, M. M., & Yin, H. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001121 · Cited by 25
miRNAs as novel immunoregulators in cancer
Lone, S. N., Bhat, A. A., Wani, N. A., Karedath, T., Hashem, S., Nisar, S., Singh, M. K., Bagga, P., Das, B. C., Bedognetti, D., et al. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.013 · Cited by 25
Tumor‐derived exosomal PD‐L1 in progression of cancer and immunotherapy
Rasihashemi, S. Z., Rezazadeh‐Gavgani, E., Majidazar, R., Seraji, P., Oladghaffari, M., Kazemi, T., & Lotfinejad, P. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30645 · Cited by 25
Millian, D. E., Saldarriaga, Ó. A., Wanninger, T. G., Burks, J. K., Rafati, Y., Gosnell, J., & Stevenson, H. L. (2022) · Cancers · doi:10.3390/cancers14081861 · Cited by 26
Kwantwi, L. B. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04833-9 · Cited by 27
Fang, Y., Zhang, X., Huang, H., & Zeng, Z. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04238-9 · Cited by 25
Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma
Pan, X., Ni, S., & Hu, K. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122481 · Cited by 26
EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
Słomka, A., Mocan, T., Wang, B., Nenu, I., Urban, S., Gonzalez-Carmona, M. A., Schmidt‐Wolf, I. G. H., Kornek, M., Strassburg, C., Sparchez, Z. A., et al. (2020) · Cancers · doi:10.3390/cancers12103019 · Cited by 24
Tumor-Intrinsic Mechanisms Regulating Immune Exclusion in Liver Cancers
Lindblad, K. E., de Galarreta, M. R., & Lujambio, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642958 · Cited by 25
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
Кипкеева, Ф. М., Музаффарова, Т. А., Коротаева, А. А., Mansorunov, D., Апанович, П. В., Nikulin, M. P., Malikhova, O. A., Стилиди, И. С., & Karpukhin, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169324 · Cited by 24
He, R., Wang, Z., Shi, W., Yu, L., Xia, H.-M., Huang, Z.-Y., Liu, S., Zhao, X.-D., Xu, Y., Yam, J., et al. (2021) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2021.111529 · Cited by 24
Wang, Z., Jiao, P., Zhong, Y., Ji, H., Zhang, Y., Song, H., Du, H., Ding, X., & Wu, H. (2022) · Cell Transplantation · doi:10.1177/09636897221083549 · Cited by 24
Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy
Syed, S. N., & Brüne, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094493 · Cited by 25
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Liu, P., Lingyu, K., Liu, Y., Li, G., Xie, J., & Lu, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135122 · Cited by 26
Tian, J.-W., Zhang, H., Siyuan, L., Guo, Y.-L., Chen, G., & Yu, Z. (2023) · Journal of Cancer · doi:10.7150/jca.84632 · Cited by 25
Emerging roles of ferroptosis-related miRNAs in tumor metastasis
Jiang, Z., Zhou, J., Deng, J., Li, L., Wang, R., Han, Y., Zhou, J., Tao, R., Peng, L., Wang, D., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01486-y · Cited by 23
Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances
Zhao, J., Li, X., Liu, L., Zhu, Z., & He, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1326667 · Cited by 26
Self-citationLiu, Y., Lu, M., Chen, J., Li, S., Deng, Y., Yang, S., Ou, Q., Li, J., Gao, P., Luo, Z., et al. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02369-1 · Cited by 23
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers
Cheng, L., Zhang, L., Wang, X., Wang, Y., Yu, J., Li, M., Ma, Z., Ho, P. C., Chen, X., Wang, L., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107419 · Cited by 22
Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy
Wei, S., Zhang, N., Zhang, H., Chen, Z., Li, S., Wu, W., Liu, Z., Xia, Z., Luo, P., & Cheng, Q. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02600-z · Cited by 25
Exosomal microRNAs in hepatocellular carcinoma
Liu, C., Wu, H., Mao, Y., Chen, W., & Chen, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01941-9 · Cited by 24
MicroRNA-23a-3p ameliorates acute kidney injury by targeting FKBP5 and NF-κB signaling in sepsis
Xu, H., & Wang, Z. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155898 · Cited by 22
Role of ER Stress in Xenobiotic‐Induced Liver Diseases and Hepatotoxicity
Zhang, Y., Qi, Y., Huang, S., Jiang, X., Xiao, W., Wang, L., Liu, Z., & Liu, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4640161 · Cited by 25
Shi, Z., Li, G., Li, Z., Liu, J., & Tang, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16652 · Cited by 22
Self-citationUnfolded protein response and angiogenesis in malignancies
Izadpanah, A., Willingham, K., Chandrasekar, B., Alt, E., & Izadpanah, R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188839 · Cited by 23
Macrophages Orchestrate the Liver Tumor Microenvironment
Quaranta, V., Ballarò, C., & Giannelli, G. (2024) · Cancers · doi:10.3390/cancers16091772 · Cited by 21
Metadata
- Authors
- Liu, J., Fan, L., Yu, H., Zhang, J., He, Y., Feng, D., Wang, F., Li, X., Liu, Q., Li, Y., Guo, Z., Gao, B., Wei, W., Wang, H., & Sun, G.
- Affiliations
- First Affiliated Hospital of Anhui Medical University (CN)
- National Institutes of Health (US)
- Anhui Medical University (CN)
- Corresponding author
- Wang, Hua
- Sun, Guoping
- ORCID
- Venue
- Hepatology
- Published
- 2019-04-25
- Volume
- 70
- Issue
- 1
- Pages
- 241-258
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC6597282
- OpenAlex
- W2922474621
- Cited by
- 449
- References
- 48
- Citations by year
- 2026: 32 · 2025: 55 · 2024: 71 · 2023: 68 · 2022: 86 · 2021: 69 · 2020: 56 · 2019: 12
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Natural Science Foundation of China (81372577, 81522009, 81770588, 81872047, 81602115, 81572430)
- National Institutes of Health
- Natural Science Foundation of Anhui Province (1608085QH195)
- National Institute on Alcohol Abuse and Alcoholism (ZIAAA000368, AA000369, Z01AA000368, Z01AA000369, AA000368, ZIAAA000369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- endoplasmic reticulum stress, hepatocellular carcinoma, exosomes, miR-23a-3p, PD-L1, tumor-associated macrophages, tumor immunosuppression, PTEN/AKT signaling, CD8+ T cells, tunicamycin, tumor microenvironment
- MeSH terms
- China, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Macrophages, T-Lymphocytes, MicroRNAs, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Exosomes, Endoplasmic Reticulum Stress, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review